Emerging trends in combinations of gefitinib and cytotoxic agents: new opportunities

Onkologie. 2005 Oct;28(10):467-70. doi: 10.1159/000088154.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Clinical Trials as Topic / trends
  • Drug Therapy / methods
  • Drug Therapy / trends
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Practice Patterns, Physicians' / trends
  • Protein Kinase Inhibitors / administration & dosage
  • Quinazolines / administration & dosage*

Substances

  • Protein Kinase Inhibitors
  • Quinazolines
  • Gefitinib